Biotest is committed to combating the coronavirus

Activities of Biotest Group against the coronavirus

TV reports, press releases and the presentation of Biotest's research activities.

CoVIg-19 PLASMA ALLIANCE

Our product range

Our development pipeline

Phase 1

Phase 2

Phase 3

Approval

Launch

IgG Next Generation (BT595) - Primary Immune Deficiency (PID)
IgG Next Generation (BT595) - Idiopathic Thrombocytopenic Purpura (ITP)
Fibrinogen (BT524) - Congenital fibrinogen deficiency
Fibrinogen (BT524) - Acquired fibrinogen deficiency
Trimodulin (BT588) - Severe community acquired pneumonia
Haemophilia A Therapeutic (HAT) - Haemophilia A

Pipeline

Overview of all projects and their status from the therapy areas Haematology, Immunology and Intensive care medicine

Press releases

Biotest proves the mode of action of trimodulin for the...

03.08.2021,

03.08.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Biotest AG opens 11th plasma collection centre in Hunga...

20.07.2021,

20.07.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Biotest receives manufacturing license for new producti...

13.07.2021,

13.07.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Preliminary announcement of the publication of quarterl...

06.07.2021,

06.07.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at ... ... [More]

Preliminary announcement of the publication of quarterl...

06.07.2021,

06.07.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at ... ... [More]

Preliminary announcement of the publication of financia...

06.07.2021,

06.07.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at ... ... [More]

Preliminary announcement of the publication of financia...

06.07.2021,

06.07.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at ... ... [More]

Preliminary announcement of the publication of financia...

06.07.2021,

06.07.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at ... ... [More]

Preliminary announcement of the publication of financia...

06.07.2021,

06.07.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at ... ... [More]

Preliminary announcement of the publication of financia...

06.07.2021,

06.07.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at ... ... [More]

Biotest AG opens fifth plasma collection centre in Czec...

30.06.2021,

30.06.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Biotest successfully completes recruitment for its clin...

02.06.2021,

02.06.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Ad-hoc RELEASE Announcement according to Article 17 Eur...

01.06.2021,

Announcement according to Article 17 European Market Abuse Regulation (MAR)Dreieich, 1 June 2021. Biotest confirms it has been informed by its major shareholder Tiancheng International Investment Limi ... [More]

Biotest increases sales by more than 22 % in the first ...

11.05.2021,

11.05.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Correction of a release from 11/05/2021, 14:30 CET/CEST...

11.05.2021,

11.05.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Annual General Meeting approves dividend distribution

11.05.2021,

11.05.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Biotest AG opens 10th plasma collection centre in Hunga...

06.05.2021,

06.05.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Biotest confirms good tolerability and efficacy of Intr...

22.04.2021,

22.04.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Biotest accelerates fibrinogen phase III study with add...

07.04.2021,

07.04.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Biotest exceeds Sales and EBIT forecast in the 2020 fin...

31.03.2021,

31.03.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Careers

Careers

Passionate to help us save lives?

Investor Relations

Investor Relations

The primary objective of our Investor Relations activities is an open and up-to-date dialogue with the financial community.